Pediatrics

Mapp Biopharmaceutical Inc

6/27/19 → 6/30/21

Project: Other project

A Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a 4 -dose Regimen of V114 in Healthy Infants (PNEU-PED)

Navarro Holguin, M.

4/29/19 → 4/28/21

Project: Other project

A Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a 4 -dose Regimen of V114 in Healthy Infants (PNEU-PED)

Texas Department of State Health Service

4/25/19 → 4/24/21

Project: Other project

Medical Child Abuse Resources and Education System (MEDCARES)

Beach, P.

3/1/19 → 8/31/20

Project: Other project

Modulation of the Allergenicity of Cedar and Ragweed Pollen Major Allergens

Midoro-Horiuti, T.

National Inst of Allergy & Infectious Di

12/1/18 → 11/30/20

Project: Other project

A Phase 3, Multicenter, Randomized, Double-blind, Active Comparator-controlled Study to Evaluate the Safety and Tolerability of V114 in Healthy Infants (PNEU-LINK)

Navarro Holguin, M.

11/29/18 → 11/28/20

Project: Other project

A Phase 3, Multicenter, Randomized, Double-blind Study to Evaluate the Interchangeability of V114 and Prevnar 13? with Respect to Safety, Tolerability, and Immunogenicity in Healthy Infants (PNEU-DIRECTION)

9/14/18 → 9/13/20

Project: Other project

Comprehensive Analysis of CMV-specific T cells in Human Subjects Receiving a Replication-defective Human Cytomegalovirus Vaccine

National Inst of Allergy & Infectious Di

8/28/18 → 8/27/20

Project: Other project

Epithelial innate signaling in airway inflammation and remodeling

Garofalo, R. P.

7/25/18 → 6/30/23

Project: Other project

A Phase IIIB, Observer-Blind, Randomized, Placebo-Controlled, Multi-Center Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine when Administered Concomitantly with Routine Vaccines to Heal

Corixa Corporation

7/9/18 → 7/8/20

Project: Other project

A PHASE 2, RANDOMIZED, OPEN-LABEL TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE VACCINE GIVEN WITH, OR SEPARATELY FROM, 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY INFANTS

ICON Clinical Research LLC

7/5/18 → 7/4/20

Project: Other project

A Double-blind, Randomized, Placebo-controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1654 in Pre-Term and Full-Term Infants

7/2/18 → 7/1/20

Project: Other project

A Phase 3, Multicenter, Randomized, Double-blind, Active Comparatorcontrolled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by Administration of PNEUMOVAX?23 Six Months Later in Immunocompetent Adults Between 18 and 49 Y

7/1/18 → 6/30/20

Project: Other project

A Phase 3, Multicenter, Randomized, Double-blind, Active Comparator controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by Administration of PNEUMOVAX?23 One Year Later in Healthy Adults 50 Years of Age or Older (PN

6/11/18 → 6/10/20

Project: Other project

A Phase III, partially modified double-blind, randomized, parallel-group, active-controlled, multi-center study to compare the immunogenicity and describe the safety of MenACYW conjugate vaccine and MENVEO? when administered concomitantly with routine pe

Sanofi Pasteur Inc

5/2/18 → 5/1/20

Project: Other project

Double-Blind, Randomized, Placebo-Controlled Phase 2b, Multi-center Study to Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of a 2-Dose and a 3- Dose Regimen of V160 (Cytomegalovirus [CMV] Vaccine) in Healthy Seronegative Women, 16 to 35

4/24/18 → 4/23/20

Project: Other project

A PHASE 2, RANDOMIZED, DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY INFANTS

Pfizer, Inc.

3/30/18 → 3/29/20

Project: Other project

A Phase II, Double-Blind, Randomized, Multicenter Trial to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Compared to Prevnar13? in Healthy Infants

2/8/17 → 2/7/20

Project: Other project

A Phase II, Double-Blind, Randomized, Multicenter Trial to Evaluate the Safety, Tolerability, and Immunogenicity of V114

Wolffarth, M.

Merck and Company

2/8/17 → 2/7/20

Project: Other project

A PHASE 3, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLINDEDS TUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER

George Washington University

Pfizer, Inc.

2/7/17 → 2/6/21

Project: Other project

The Dynamics of Nasal Bacterial Ecology and S. aureus Antagonism

Pyles, R.

6/1/16 → 5/31/20

Project: Other project

Role of tRNA-derived RNA Fragments (tRFs) in Respiratory Syncytia Virus (RSV) Infection

Bao, X.

National Inst of Allergy & Infectious Di

12/1/15 → 11/30/20

Project: Other project

Early Childhood Intervention

9/1/09 → 8/31/20

Project: Other project

Early Childhood Intervention (84.181)

9/1/09 → 8/30/20

Project: Other project

Early Childhood Intervention - ARRA

9/1/09 → 8/31/20

Project: Other project

Early Childhood Intervention (84.027)

9/1/09 → 8/31/20

Project: Other project

Early Childhood Intervention (93.558)

9/1/09 → 8/31/20

Project: Other project

Early Childhood Intervention (84.393)

9/1/09 → 8/31/20

Project: Other project

Completed

An Expanded Access Treatment Protocol for Zmapp TM for Patients with Ebola Virus Disease (EVD) or Ebola Virus Exposure

ICON Government & Public Health Solution

5/1/18 → 6/26/19

Project: Other project

Protocol 63623872FLZ3002: A Phase 3 Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-care Treatment in Adolescent, Adult, and Elderly Non-hospitalized

Janssen Pharmaceutica NV

2/5/18 → 12/31/19

Project: Other project

Protocol 63623872FLZ3002: A Phase 3 Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-care Treatment in Adolescent, Adult, and Elderly Non-hospitalized

Janssen Pharmaceutical Research & Develo

2/5/18 → 12/31/19

Project: Other project

A Phase I Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of Live-Attenuated Tetravalent Dengue Vaccine (V181) in Flavivirus-Naive and Flavivirus-Experienced Health Adults (MK-V181-001-01)

1/4/18 → 1/3/20

Project: Other project

IMPAACT 2021 startup

Johns Hopkins University

1/1/18 → 11/30/19

Project: Other project

A Phase 3, Double-Blind, Randomized, Multicenter, Controlled Study to Evaluate the Immunogenicity, Safety, and Tolerability of VARIVAX Passage Extension 34 (PE34) Process Administered Concomitantly with M-M-R II

8/21/17 → 8/20/19

Project: Other project

lmmunogenicity, reactogenicityan safetystudyof Pediarix, Hiberix, and Prevnar 13 co-administered with two diff'erent formulations of GSK Biologicals' HRVvaccine ( 444563) in healthy infants 6-12 weeks of age

GlaxoSmithKline Pharmaceuticals

8/18/17 → 8/17/19

Project: Other project

Vaccine and Treatment Evaluation Units (VTEU) Overall Administration, Clinical Operations Support and Concept and Protocol Development and Implementation for Task Areas B & C Task Order FY.2017.B8C12.0080

BAYLOR COLLEGE OF MEDICINE

7/28/17 → 7/27/19

Project: Other project

HSV testing in animal models

Bourne, N.

Conrad

5/1/17 → 10/15/18

Project: Other project

A Phase 2b Randomized, Double-blind, Placebo-Controlled Study of Evaluate and Efficacy of MEDI8897, a Monoclonal Antibody with an extended Half-life Against Respiratory Syncytial Virus in Healthy Preterm Infants

Patel, J.

AstraZeneca LP

10/28/16 → 10/27/18

Project: Other project

GV29893 A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED TRIAL OF MHAA4549A, A MONOCLONAL ANTIBODY, ADMINISTERED AS MONOTHERAPY FOR THE TREATMENT OF ACUTE UNCOMPLICATED SEASONAL INFLUENZA A INFECTION IN OTHERWISE HEALTHY ADULTS

Genentech, Inc.

10/27/16 → 10/26/18

Project: Other project

Vaccine and Treatment Evaluation Units (VTEU) Protocol Development, Implementation and Assays Task Area B-D Task Order 15-0066.B1C1D1.0041